77
65
Growth Score
-6 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
1036405
F3 Platform Biologics is a biopharmaceutical company that provides solutions to low-dose radiation exposure.
James Miller: Chief Operating Officer- Jonathan Peskoff: Chief Executive Officer & Co-Founder
About the Company
F3 Platform Biologics is a biopharmaceutical company that provides solutions to low-dose radiation exposure. The company specializes in reducing the unpredictable impacts of radiation, which become more likely as doses or exposures increase. These effects include genetic mutations and cancers.
F3 possesses a global exclusive license from the
University of Chicago, as well as multiple patents, enabling the development of specific applications for amifostine in various markets. The company aims to introduce this scientific innovation to the market, aiming to prevent diseases, preserve lives, and enhance the quality of life on a global scale.
